Pharma Journalist -

Aimmune Therapeutics announced that Nestlé Health Science will make an additional equity investment in Aimmune of $98 million, increasing Nestlé Health Science’s ownership of Aimmune to…
Read More...

Pain Therapeutics announced that it has petitioned the Food & Drug Administration (FDA) regarding a Complete Response Letter (CRL) for REMOXY issued August 2018.  The FDA and the…
Read More...

Metrics Contract Services (Metrics), a division of Mayne Pharma Group Limited, announced successful qualification of two commercial bottling lines for serialization at its new US$80…
Read More...

BridgeBio Pharma LLC and Cincinnati Children's Hospital Medical Center announced that they are entering into a research collaboration to identify and develop genetic disease therapies.…
Read More...

Ziopharm Oncology announced a clinical supply agreement with Regeneron Pharmaceuticals, Inc. to evaluate Ziopharm’s Ad-RTS-hIL-12 plus veledimex in combination with Regeneron’s PD-1…
Read More...

CRISPR Therapeutics and MaxCyte announced the expansion of their existing relationship by entering into a non-exclusive commercial license agreement that will allow CRISPR Therapeutics…
Read More...

More so than ever injectable drugs are administered using devices like pre-filled syringes, auto-injectors, and pen-injectors. Patient-centricity is driving the future of the injectable…
Read More...

Genkyotex announced that its lead product candidate GKT831, a NOX1/4 inhibitor, met both the primary and secondary interim efficacy endpoints with high statistical significance after…
Read More...

Lonza announced that the recombinant Factor C (rFC) Assay has been used for endotoxin testing of Eli Lilly’s Emgality (galcanezumab), the first drug approved by the U.S. Food and Drug…
Read More...

BioTime and Asterias Biotherapeutics announced that they have entered into a definitive merger agreement whereby BioTime will acquire all of the remaining outstanding common stock of…
Read More...